TABLE 2 .
Primary outcomes by HAI and NAI titer groups
| Outcome | No. of subjects (%) with outcome in the HAI titer group |
P valuea | No. of subjects (%) with outcome in the NAI titer group |
P valuea | ||
|---|---|---|---|---|---|---|
| High (n = 25) | Low (n = 40) | High (n = 54) | Low (n = 11) | |||
| MMID (shedding + symptoms) | 6 (24) | 29 (72) | <0.001* | 24 (44) | 11 (100) | <0.001* |
| No MMID (shedding + symptoms) | 19 (76) | 11 (28) | 30 (56) | 0 (0) | ||
| Symptoms | 20 (80) | 35 (88) | 0.489 | 44 (81) | 11 (100) | 0.190 |
| No symptoms | 5 (20) | 5 (12) | 10 (19) | 0 (0) | ||
a
Fisher’s exact P value for the difference in the number of subjects in the two groups (high- and low-titer groups) (n = 65). The statistically significant P value is indicated with an asterisk.